Results 11 to 20 of about 8,578 (226)

Rapid Improvement of Hyperpigmentation, Growth, and Developmental Milestones With High-Dose Hydroxocobalamin, Betaine, and Folinic Acid Treatment: The First Patient With Cobalamin G Deficiency in Taiwan. [PDF]

open access: goldJIMD Rep
ABSTRACT In this report, we present the case of a 16‐month‐old patient who was diagnosed with cobalamin G deficiency at 4 months of age via whole exome sequencing by detecting compound heterozygous variants of uncertain significance (VUS) in the MTR gene: (1) c.1283T>A, p.Met428Lys; (2) c.2411T>C, p.Ile804Thr. Before the diagnosis, the initial clinical
Wu CT, Huang SJ, Chen CC, Chiu PC.
europepmc   +3 more sources

Improved biochemical and neurodevelopmental profiles with high‐dose hydroxocobalamin therapy in cobalamin C defect

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 1, January 2025.
Cobalamin C (Cbl‐C) defect causes methylmalonic acidemia, homocystinuria, intellectual disability and visual impairment, despite treatment adherence. While international guidelines recommend parenteral hydroxocobalamin (OH‐Cbl) as effective treatment ...
G. Olivieri   +10 more
semanticscholar   +2 more sources

Hydroxocobalamin versus Cyanocobalamin [PDF]

open access: bronzeJournal of the Royal Society of Medicine, 1996
Anthony G Freeman
openalex   +3 more sources

Hydroxocobalamin for the treatment of vasoplegia after lung transplantation: A case series. [PDF]

open access: goldJHLT Open
Nguyen A   +10 more
europepmc   +2 more sources

Effect of hydroxocobalamin on nimodipine-induced refractory vasoplegia in a patient with liver cirrhosis

open access: diamondJournal of Neurocritical Care
Background: We report a case of severe vasoplegia that was unresponsive to triple vasopressor therapy but showed marked hemodynamic improvement following intravenous hydroxocobalamin administration in a patient with underlying cirrhosis.Case Report: A 63-
Sungyong You
openalex   +2 more sources

The effect of hydroxocobalamin and methylene blue for vasoplegic syndromes: A systematic review

open access: goldElectronic Journal of General Medicine
Background: The role of methylene blue (MB) and hydroxocobalamin (B12) in treating patients with vasoplegic syndromes remains uncertain. Objective: This systematic review aimed to assess the effects of MB and hydroxocobalamin on patients with vasoplegic ...
Wahyu Mananda   +5 more
openalex   +2 more sources

Analysis of hydroxocobalamin dosage in patients with CblC deficiency. [PDF]

open access: goldOrphanet J Rare Dis
Ding S   +18 more
europepmc   +2 more sources

Seeing Red: Hydroxocobalamin and Result Interference.

open access: yesJournal of Cardiothoracic and Vascular Anesthesia, 2023
J. Ortoleva, Alexander D. Shapeton
semanticscholar   +3 more sources

Home - About - Disclaimer - Privacy